Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PTC Therapeutics, Inc. - Common Stock
(NQ:
PTCT
)
73.69
+9.20 (+14.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PTC Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Analyst Expectations for PTC Therapeutics's Future
↗
November 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 27, 2023
Via
Benzinga
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
↗
October 27, 2023
In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a
Via
Benzinga
ALGN Stock Alert: Align Technology Announces $250M Stock Buyback Program
↗
October 27, 2023
Align Technology stock is rising on Friday after the company announced plans to repurchase $250 million worth of ALGN shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 27, 2023
Via
Benzinga
Earnings Preview: PTC Therapeutics
↗
October 25, 2023
Via
Benzinga
Expert Ratings for PTC Therapeutics
↗
September 19, 2023
Via
Benzinga
RBLX Stock Alert: Analysts Are Pounding the Table on Roblox
↗
October 27, 2023
Roblox stock is rising higher on Friday after analysts upgraded shares of RBLX and increased price targets for the gaming company.
Via
InvestorPlace
Why Is PTC Therapeutics (PTCT) Stock Down 23% Today?
↗
October 27, 2023
PTC Therapeutics stock is falling on Friday as PTCT investors react to the company's lackluster earnings report for Q3 2023.
Via
InvestorPlace
Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday
↗
October 27, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
October 27, 2023
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 26, 2023
Via
Benzinga
Why PTC Therapeutics Soared 15% Higher Today
↗
October 19, 2023
The company scored a $1 billion upfront payment for expanding a commercial partnership.
Via
The Motley Fool
Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
↗
October 19, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The...
Via
Benzinga
Topics
Stocks
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
↗
October 19, 2023
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
October 19, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 19, 2023
Via
Benzinga
NASDAQ:PTCT Shareholder Notice: Investigation over Possible Securities Laws Violations by PTC Therapeutics, Inc.
↗
October 10, 2023
San Diego, CA -- (SBWIRE) -- 10/10/2023 -- PTC Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
↗
October 06, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
October 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
October 02, 2023
On Monday, 369 companies set new 52-week lows.
Via
Benzinga
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
↗
September 19, 2023
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
↗
September 18, 2023
Via
Benzinga
Micron Technology To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday
↗
September 18, 2023
Piper Sandler cut the price target for IBEX Limited (NASDAQ: IBEX) from $24 to $17. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. IBEX shares rose 0.3% to close at $13.59 on...
Via
Benzinga
US Stock Futures Edge Higher Amid Cautious Optimism; Analyst Says How Fed Packages Sept. Pause Key For Market Direction
↗
September 18, 2023
US stock futures point to a higher opening on Monday after averages closed nearly flat in the week ended Sept. 15.
Via
Benzinga
Topics
Economy
European Authority Gives Thumbs Down To PTC Therapeutics' Duchenne Therapy; Analyst Says It Can Overturn The Challenge
↗
September 15, 2023
Friday morning, the Committee for Medicinal Products for Human Use of the European Medicines Agency gave a negative opinion on the conversion of the conditional marketing authorization to full...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 15, 2023
Via
Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
Nasdaq Down Over 1%; US Industrial Output Rises In August
↗
September 15, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The...
Via
Benzinga
Topics
Stocks
Stocks That Hit 52-Week Lows On Friday
↗
September 15, 2023
Friday's session saw 169 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
